Amoxicillin Drug Market (2024 - 2034)

Amoxicillin Drug Market Study by Skin Infections, ENT, Stomach Infections, Lung Infections, Urinary Tract Infections, Pneumonia, Bronchitis, and Gonorrhea From 2024 to 2034

Free Sample

Core Findings

    Amoxicillin Drug Market Outlook (2024 to 2034)

    The global amoxicillin drug market is currently valued at US$ 4.48 billion in 2024 and is forecasted to expand at a CAGR of 4% to reach US$ 6.64 billion by 2034.

    Amoxicillin comes under widely prescribed antibiotics globally. According to some reports in 2023, around 18.26% of all antibiotic prescriptions in outpatient settings were for amoxicillin with nearly 270 million total antibiotic prescriptions, this accounts for nearly 49 million prescriptions for amoxicillin in the United States alone. This usage is further projected to keep escalating worldwide with varying volumes by region.

    In Europe, Asia Pacific, and America, it is the leading antibiotic, primarily used for bacterial infections, such as respiratory tract infections, otitis media, and skin conditions.

    Seeing these demands, several manufacturers have expanded their production volumes with China heading on top with 40% annual production, followed by India with 25%. More manufacturers for this reason are investing a hefty amount in the East Asia region to establish their production centers to keep themselves in the profit circle.

    The demand for amoxicillin is also increasing due to more than average people facing respiratory issues, such as RSV, flu, and COVID-19. This surge in infection, especially among children is leading to a higher need for antibiotics, including amoxicillin, which is commonly prescribed for ears, throat, and respiratory infections.

    In the United States, the FDA has identified a shortage of amoxicillin oral suspension particularly especially for pediatric patients. This is crucial for treating children, these shortages are going to work positively for manufacturers in China and India, making the market grow significantly in the East Asian region.

    Major significant advancements are becoming obvious in this market; one significant advancement is the development of amoxicillin-clavulanate combinations, which help in inhibiting the beta-lactamase enzymes enhancing the overall effectiveness against a broader spectrum of infections.

    Several researchers are also putting their effort into investigating combining amoxicillin with other antimicrobial agents, such as beta-lactamase inhibitors to boost efficacy against multi-drug-resistant organisms. These innovations highlight all the ongoing efforts to ensure that amoxicillin remains an effective treatment option while also addressing the rising challenge of antibiotic resistance and improving patient access to the drug in high-demand periods.

    Report Attribute Detail
    Amoxicillin Drug Market Size (2024E) US$ 4.48 Billion
    Forecasted Market Value (2034F) US$ 6.64 Billion
    Global Market Growth Rate (2024 to 2034) 4% CAGR
    East Asia Market Value (2034F) US$ 1.27 Billion
    North America Market Growth Rate (2034F) 3.9%
    Oral Segment Value (2034F) US$ 5.29 Billion
    Japan Market Value (2034F) US$ 298.48 Million
    Key Companies Profiled Novartis; Dr. Reddy Laboratories; JAMP Pharma Corporation; Northwind Pharmaceuticals; Profecient Ex LP; Sun Pharmaceuticals

    Amoxicillin drugs is a form of generic drugs of Amoxil branded drug commonly used in the treatment of bacterial infections. The amoxicillin drugs fall under the drug class of β-lactam antibiotics. The increasing number of bacterial infections around the world, especially, in developing and low-income countries is one of the reasons for the growing demand for amoxicillin drugs and hence, boosting the growth of the amoxicillin drug market.

    In the 1980s, the Food and Drug Administration (FDA) first approved amoxicillin drug.

    The surveillance released by the World Health Organization (WHO) showed that in high- and low-income countries increasing levels of antibiotic resistance to several serious bacterial infections. The Global Antimicrobial Surveillance System (GLASS) showed the occurrence of widespread antibiotic resistance among 500,000 people with a high risk of bacterial infections across 22 countries.

    However, amoxicillin drugs are suggested not to be taken if the patients are allergic to any kind of penicillin antibiotic or amoxicillin. Some people do not know if they have infections or not, due to which patients go through some serious complications. This restrains the growth of the amoxicillin drug market.

    Amoxicillin Drugs: Market Dynamics

    Today, there is a variety of branded and generic versions of amoxicillin drugs are available in the market. Several drug manufacturers are manufacturing amoxicillin drugs and distributing them in the market.

    The amoxicillin drugs are also used a combination with other drugs used to treat a bacterial infection, such as triple therapy (amoxicillin/clarithromycin/lansoprazole) and dual therapy (amoxicillin/lansoprazole). These dual and triple therapies are under clinical trials.

    The rising number of clinical trials to check the efficacy and effects of combination drugs with amoxicillin drugs is expected to drive the growth of the amoxicillin drug market in the forecast period. However, the most common adverse effects observed in clinical trials on combination drugs are diarrhea, vomiting, rash, and nausea.

    This delays the marketing of combination drugs in the market and hampers the growth of the amoxicillin drug market in the forecast period.

    Amoxicillin Drug Market: Overview

    According to the World Health Organization (WHO), the most common resistant bacteria reported were Escherichia coli, Staphylococcus aureus, Streptococcus pneumonia, Salmonella spp., and Klebsiella pneumonia. Moreover, several forms are available for amoxicillin drugs in the market, such as tablets, capsules, suspensions, powder, and syrup.

    For people who find difficulty in taking tablets or capsules, suspension, syrup, or powdered form amoxicillin drugs are used. Suspension amoxicillin drugs are widely used by pediatric patients. Amoxicillin drugs are available in a wide variety of distribution channels. These factors are expected to boost the growth of the amoxicillin drug market.

    Amoxicillin Drug Market: Region-wise Outlook

    North America is expected to show the highest revenue growth due to high investment in clinical trials and R&D spending, followed by Europe. The amoxicillin drug market in the Asia-Pacific region is expected to show high CAGR growth due to the large patient pool who are at high risk of bacterial infections because of poor sanitation, unsafe drinking water, and high population.

    Latin America and the Middle East & Africa are also at high risk of bacterial infections due unavailability of safe water.

    Amoxicillin Drug Market: Key Players

    Some of the key players present in the global amoxicillin drug market are JAMP Pharma Corporation, Novartis, Dr. Reddy's Laboratories, Sun Pharmaceuticals, Proficient Rx LP., Sanis Health Inc., Nucare Pharmaceuticals, Inc., Northwind Pharmaceuticals, A-S Medication Solutions, Bryant ranch prepack and others.

    The report covers an exhaustive analysis on :

    • Market Segments
    • Market Dynamics
    • Market Size
    • Current Trends/Issues/Challenges
    • Competition & Companies involved
    • Value Chain

    The regional analysis includes :

    • North America (United States, Canada)
    • Latin America (Mexico. Brazil)
    • Western Europe (Germany, Italy, France, United Kingdom, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
    • Eastern Europe (Poland, Russia)
    • The Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
    • Japan
    • The Middle East and Africa (GCC, S. Africa, N. Africa)

    The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of several market factors on market segments and geographies.

    Report Highlights :

    • Detailed overview of parent market
    • Changing market dynamics in the industry
    • In-depth market segmentation
    • Historical, current, and projected market size in terms of volume and value
    • Recent industry trends and developments
    • Competitive landscape
    • Strategies of key players and products offered
    • Potential and niche segments, geographical regions exhibiting promising growth
    • A neutral perspective on market performance

    Segmentation of Amoxicillin Drug Market Research

    • By Infection Type :

      • Skin Infection
      • ENT
      • Stomach Infection
      • Lungs Infection
      • Urinary Tract Infection
      • Pneumonia
      • Bronchitis
      • Gonorrhea

    • By Route of Administration :

      • Oral
      • Intravenous

    • By Form :

      • Tablets
      • Capsules
      • Suspensions
      • Syrups
      • Powder

    • By Distribution Channel :

      • Hospitals Pharmacies
      • Drug Stores
      • Retail Stores
      • Online Pharmacies

    • By Region :

      • North America
      • Western Europe
      • Eastern Europe
      • Latin America
      • East Asia
      • South Asia & Pacific
      • Middle East & Africa

    Table of Content

    • 1. Executive Summary
    • 2. Industry Introduction, including Taxonomy and Market Definition
    • 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
    • 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
    • 5. Pricing Analysis
    • 6. Global Market Analysis and Forecast
      • 6.1. Infection Type
      • 6.2. Route Of Administration
      • 6.3. Form
      • 6.4. Distribution Channels
    • 7. Global Market Analysis and Forecast, By Infection Type
      • 7.1. Skin Infections
      • 7.2. ENT (Ear, Nose & Throat) Infections
      • 7.3. Stomach Infections
      • 7.4. Lungs Infections
      • 7.5. Urinary Tract Infections (UTI)
      • 7.6. Pneumonia
      • 7.7. Bronchitis
      • 7.8. Gonorrhea
    • 8. Global Market Analysis and Forecast, By Route Of Administration
      • 8.1. Oral
      • 8.2. Intravenous
    • 9. Global Market Analysis and Forecast, By Form
      • 9.1. Tablets
      • 9.2. Capsule
      • 9.3. Suspensions
      • 9.4. Syrup
      • 9.5. Powder
    • 10. Global Market Analysis and Forecast, By Distribution Channels
      • 10.1. Hospitals Pharmacies
      • 10.2. Drug Stores
      • 10.3. Retail Stores
      • 10.4. Online Pharmacies
    • 11. Global Market Analysis and Forecast, By Region
      • 11.1. North America
      • 11.2. Latin America
      • 11.3. Western Europe
      • 11.4. Eastern Europe
      • 11.5. Asia Pacific
      • 11.6. East Asia
      • 11.7. MEA
    • 12. North America Sales Analysis and Forecast, by Key Segments and Countries
    • 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
    • 14. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
    • 15. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
    • 16. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
    • 17. East Asia Sales Analysis and Forecast, by Key Segments and Countries
    • 18. MEA Sales Analysis and Forecast, by Key Segments and Countries
    • 19. Sales Forecast by Infection Type, Route Of Administration, Form, and Distribution Channels for 30 Countries
    • 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
    • 21. Company Profile
      • 21.1. JAMP Pharma Corporation
      • 21.2. Novartis
      • 21.3. Dr. Reddy's Laboratories
      • 21.4. Sun Pharmaceuticals
      • 21.5. Proficient Rx LP
      • 21.6. Sanis Health Inc
      • 21.7. Nucare Pharmaceuticals, Inc.
      • 21.8. Northwind Pharmaceuticals
      • 21.9. A-S Medication Solutions

    List Of Table

    Table 1: Global Market US$ Mn Forecast by Region

    Table 2: Global Market US$ Mn Forecast by Infection Type

    Table 3: Global Market US$ Mn Forecast by Route Of Administration

    Table 4: Global Market US$ Mn Forecast by Form

    Table 5: Global Market US$ Mn Forecast by Distribution Channels

    Table 6: North America Market US$ Mn Forecast by Country

    Table 7: North America Market US$ Mn Forecast by Infection Type

    Table 8: North America Market US$ Mn Forecast by Route Of Administration

    Table 9: North America Market US$ Mn Forecast by Form

    Table 10: North America Market US$ Mn Forecast by Distribution Channels

    Table 11: Latin America Market US$ Mn Forecast by Country

    Table 12: Latin America Market US$ Mn Forecast by Infection Type

    Table 13: Latin America Market US$ Mn Forecast by Route Of Administration

    Table 14: Latin America Market US$ Mn Forecast by Form

    Table 15: Latin America Market US$ Mn Forecast by Distribution Channels

    Table 16: Western Europe Market US$ Mn Forecast by Country

    Table 17: Western Europe Market US$ Mn Forecast by Infection Type

    Table 18: Western Europe Market US$ Mn Forecast by Route Of Administration

    Table 19: Western Europe Market US$ Mn Forecast by Form

    Table 20: Western Europe Market US$ Mn Forecast by Distribution Channels

    Table 21: Eastern Europe Market US$ Mn Forecast by Country

    Table 22: Eastern Europe Market US$ Mn Forecast by Infection Type

    Table 23: Eastern Europe Market US$ Mn Forecast by Route Of Administration

    Table 24: Eastern Europe Market US$ Mn Forecast by Form

    Table 25: Eastern Europe Market US$ Mn Forecast by Distribution Channels

    Table 26: Asia Pacific Market US$ Mn Forecast by Country

    Table 27: Asia Pacific Market US$ Mn Forecast by Infection Type

    Table 28: Asia Pacific Market US$ Mn Forecast by Route Of Administration

    Table 29: Asia Pacific Market US$ Mn Forecast by Form

    Table 30: Asia Pacific Market US$ Mn Forecast by Distribution Channels

    Table 31: East Asia Market US$ Mn Forecast by Country

    Table 32: East Asia Market US$ Mn Forecast by Infection Type

    Table 33: East Asia Market US$ Mn Forecast by Route Of Administration

    Table 34: East Asia Market US$ Mn Forecast by Form

    Table 35: East Asia Market US$ Mn Forecast by Distribution Channels

    Table 36: MEA Market US$ Mn Forecast by Country

    Table 37: MEA Market US$ Mn Forecast by Infection Type

    Table 38: MEA Market US$ Mn Forecast by Route Of Administration

    Table 39: MEA Market US$ Mn Forecast by Form

    Table 40: MEA Market US$ Mn Forecast by Distribution Channels

    List Of Figures

    Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type

    Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration

    Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form

    Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

    Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region

    Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type

    Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration

    Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form

    Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

    Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

    Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type

    Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration

    Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form

    Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

    Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

    Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type

    Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration

    Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form

    Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

    Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

    Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type

    Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration

    Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form

    Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

    Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

    Figure 26: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type

    Figure 27: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration

    Figure 28: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form

    Figure 29: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

    Figure 30: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

    Figure 31: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type

    Figure 32: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration

    Figure 33: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form

    Figure 34: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

    Figure 35: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

    Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type

    Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration

    Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form

    Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

    Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

    - Frequently Asked Questions -

    What is the key trend in the amoxicillin drug market?

    Rising Number of clinical trials to check the efficacy drives amoxicillin drug market growth.

    Which route of administration drives the most demand for the amoxicillin drug market?

    he intravenous route of administration is contributing to market prospects.

    Related Reports

    Related Reports

    Amoxicillin Drug Market

    Copyright © Fact.MR All Rights Reserved

    An initiative of Eminent Research and Advisory Services